Controlled-release Drug Delivery Technology Market Report

China Controlled-release Drug Delivery Technology Market Professional Research Report 2022-2027, Segmented by Players, Types, End-Users in Major Regions

  • POSTDATE：Aug 25, 2022
  • PAGES：169
  • REPORT CODE：GMM1172086
  • REPORT SUMMARY
  • TABLE OF CONTENTS

  • This report offers an overview of the market trends, drivers, and barriers with respect to the China Controlled-release Drug Delivery Technology market. It also provides a detailed overview of the market of different regions across North China, Central China, South China, East China, Northeast China, Southwest China, Northwest China. The report deep analyzes type and application in China Controlled-release Drug Delivery Technology market. Detailed analysis of key players, along with key growth strategies adopted by Controlled-release Drug Delivery Technology industry, the PEST and SWOT analysis are also included. In short, the report will provide a comprehensive view of the industry's development and features.

    By Player:

    • iCeutica

    • Heron Therapeutics

    • Encore Therapeutics

    • Biogen

    • Cosmo Pharmaceuticals

    • Allergan

    • AstraZeneca

    • GlaxoSmithKline

    • Elan Corporation

    • Amylin Pharmaceuticals

    • Egalet

    • Flamel Technologies

    • Collegium Pharmaceutical

    • BioAlliance Pharma

    • Controlled Therapeutics (Ferring Pharmaceuticals)

    By Type:

    • Wurster Technique

    • Coacervation

    • Micro Encapsulation

    • Implants

    • Transdermal

    • Targeted Delivery

    • Others

    By End-User:

    • Metered Dose Inhalers

    • Injectables

    • Transdermal and Ocular Patches

    • Infusion Pumps

    • Oral Controlled-Drug Delivery Systems

    • Drug Eluting Stents

    • Other

    By Region:

    • North China

    • Central China

    • South China

    • East China

    • Northeast China

    • Southwest China

    • Northwest China

  • TABLE OF CONTENT

    1 Report Overview

    • 1.1 Product Definition and Scope

    • 1.2 PEST (Political, Economic, Social and Technological) Analysis of Controlled-release Drug Delivery Technology Market

    • 1.3 Market Segment by Type

    • 1.3.1 China Controlled-release Drug Delivery Technology Market Size and Growth Rate of Wurster Technique from 2016 to 2027

    • 1.3.2 China Controlled-release Drug Delivery Technology Market Size and Growth Rate of Coacervation from 2016 to 2027

    • 1.3.3 China Controlled-release Drug Delivery Technology Market Size and Growth Rate of Micro Encapsulation from 2016 to 2027

    • 1.3.4 China Controlled-release Drug Delivery Technology Market Size and Growth Rate of Implants from 2016 to 2027

    • 1.3.5 China Controlled-release Drug Delivery Technology Market Size and Growth Rate of Transdermal from 2016 to 2027

    • 1.3.6 China Controlled-release Drug Delivery Technology Market Size and Growth Rate of Targeted Delivery from 2016 to 2027

    • 1.3.7 China Controlled-release Drug Delivery Technology Market Size and Growth Rate of Others from 2016 to 2027

    • 1.4 Market Segment by Application

    • 1.4.1 China Controlled-release Drug Delivery Technology Market Size and Growth Rate of Metered Dose Inhalers from 2016 to 2027

    • 1.4.2 China Controlled-release Drug Delivery Technology Market Size and Growth Rate of Injectables from 2016 to 2027

    • 1.4.3 China Controlled-release Drug Delivery Technology Market Size and Growth Rate of Transdermal and Ocular Patches from 2016 to 2027

    • 1.4.4 China Controlled-release Drug Delivery Technology Market Size and Growth Rate of Infusion Pumps from 2016 to 2027

    • 1.4.5 China Controlled-release Drug Delivery Technology Market Size and Growth Rate of Oral Controlled-Drug Delivery Systems from 2016 to 2027

    • 1.4.6 China Controlled-release Drug Delivery Technology Market Size and Growth Rate of Drug Eluting Stents from 2016 to 2027

    • 1.4.7 China Controlled-release Drug Delivery Technology Market Size and Growth Rate of Other from 2016 to 2027

    • 1.5 Market Segment by Regions

      • 1.5.1 North China Controlled-release Drug Delivery Technology Consumption Market Size and Growth Rate from 2016 to 2027

      • 1.5.2 Central China Controlled-release Drug Delivery Technology Consumption Market Size and Growth Rate from 2016 to 2027

      • 1.5.3 South China Controlled-release Drug Delivery Technology Consumption Market Size and Growth Rate from 2016 to 2027

      • 1.5.4 East China Controlled-release Drug Delivery Technology Consumption Market Size and Growth Rate from 2016 to 2027

      • 1.5.5 Northeast China Controlled-release Drug Delivery Technology Consumption Market Size and Growth Rate from 2016 to 2027

      • 1.5.6 Southwest China Controlled-release Drug Delivery Technology Consumption Market Size and Growth Rate from 2016 to 2027

      • 1.5.7 Northwest China Controlled-release Drug Delivery Technology Consumption Market Size and Growth Rate from 2016 to 2027

    2 Market Trends and Competitive Landscape

    • 2.1 Market Trends and Dynamics

      • 2.1.1 Market Challenges and Restraints

      • 2.1.2 Market Opportunities and Potentials

      • 2.1.3 Mergers and Acquisitions

    • 2.2 Competitive Landscape Analysis

      • 2.2.1 Industrial Concentration Analysis

      • 2.2.2 Porter's Five Forces Analysis of the Industry

      • 2.2.3 SWOT Analysis for New Entrants

    • 2.3 Coronavirus (COVID-19) Distribution and its Impact on the Industry

    3 Segmentation of Controlled-release Drug Delivery Technology Market by Types

    • 3.1 Products Development Trends of Different Types

    • 3.2 Commercial Products Types of Major Vendors

    • 3.3 Competitive Landscape Analysis of Different Types

    • 3.4 Market Size of Controlled-release Drug Delivery Technology by Major Types

    • 3.4.1 Market Size and Growth Rate of Wurster Technique

    • 3.4.2 Market Size and Growth Rate of Coacervation

    • 3.4.3 Market Size and Growth Rate of Micro Encapsulation

    • 3.4.4 Market Size and Growth Rate of Implants

    • 3.4.5 Market Size and Growth Rate of Transdermal

    • 3.4.6 Market Size and Growth Rate of Targeted Delivery

    • 3.4.7 Market Size and Growth Rate of Others

    4 Segmentation of Controlled-release Drug Delivery Technology Market by End-Users

    • 4.1 Downstream Client Analysis by End-Users

    • 4.2 Competitive Landscape Analysis of Different End-Users

    • 4.3 Market Potential Analysis of Different End-Users

    • 4.4 Market Size of Controlled-release Drug Delivery Technology by Major End-Users

    • 4.4.1 Market Size and Growth Rate of Controlled-release Drug Delivery Technology in Metered Dose Inhalers

    • 4.4.2 Market Size and Growth Rate of Controlled-release Drug Delivery Technology in Injectables

    • 4.4.3 Market Size and Growth Rate of Controlled-release Drug Delivery Technology in Transdermal and Ocular Patches

    • 4.4.4 Market Size and Growth Rate of Controlled-release Drug Delivery Technology in Infusion Pumps

    • 4.4.5 Market Size and Growth Rate of Controlled-release Drug Delivery Technology in Oral Controlled-Drug Delivery Systems

    • 4.4.6 Market Size and Growth Rate of Controlled-release Drug Delivery Technology in Drug Eluting Stents

    • 4.4.7 Market Size and Growth Rate of Controlled-release Drug Delivery Technology in Other

    5 Market Analysis by Regions

    • 5.1 China Controlled-release Drug Delivery Technology Production Analysis by Regions

    • 5.2 China Controlled-release Drug Delivery Technology Consumption Analysis by Regions

    • 5.3 Coronavirus (COVID-19) Impact on China Economy

    6 North China Controlled-release Drug Delivery Technology Landscape Analysis

    • 6.1 North China Controlled-release Drug Delivery Technology Landscape Analysis by Major Types

    • 6.2 North China Controlled-release Drug Delivery Technology Landscape Analysis by Major End-Users

    7 Central China Controlled-release Drug Delivery Technology Landscape Analysis

    • 7.1 Central China Controlled-release Drug Delivery Technology Landscape Analysis by Major Types

    • 7.2 Central China Controlled-release Drug Delivery Technology Landscape Analysis by Major End-Users

    8 South China Controlled-release Drug Delivery Technology Landscape Analysis

    • 8.1 South China Controlled-release Drug Delivery Technology Landscape Analysis by Major Types

    • 8.2 South China Controlled-release Drug Delivery Technology Landscape Analysis by Major End-Users

    9 East China Controlled-release Drug Delivery Technology Landscape Analysis

    • 9.1 East China Controlled-release Drug Delivery Technology Landscape Analysis by Major Types

    • 9.2 East China Controlled-release Drug Delivery Technology Landscape Analysis by Major End-Users

    10 Northeast China Controlled-release Drug Delivery Technology Landscape Analysis

    • 10.1 Northeast China Controlled-release Drug Delivery Technology Landscape Analysis by Major Types

    • 10.2 Northeast China Controlled-release Drug Delivery Technology Landscape Analysis by Major End-Users

    11 Southwest China Controlled-release Drug Delivery Technology Landscape Analysis

    • 11.1 Southwest China Controlled-release Drug Delivery Technology Landscape Analysis by Major Types

    • 11.2 Southwest China Controlled-release Drug Delivery Technology Landscape Analysis by Major End-Users

    12 Northwest China Controlled-release Drug Delivery Technology Landscape Analysis

    • 12.1 Northwest China Controlled-release Drug Delivery Technology Landscape Analysis by Major Types

    • 12.2 Northwest China Controlled-release Drug Delivery Technology Landscape Analysis by Major End-Users

    13 Major Players Profiles

    • 13.1 iCeutica

      • 13.1.1 iCeutica Company Profile and Recent Development

      • 13.1.2 Market Performance

      • 13.1.3 Product and Service Introduction

    • 13.2 Heron Therapeutics

      • 13.2.1 Heron Therapeutics Company Profile and Recent Development

      • 13.2.2 Market Performance

      • 13.2.3 Product and Service Introduction

    • 13.3 Encore Therapeutics

      • 13.3.1 Encore Therapeutics Company Profile and Recent Development

      • 13.3.2 Market Performance

      • 13.3.3 Product and Service Introduction

    • 13.4 Biogen

      • 13.4.1 Biogen Company Profile and Recent Development

      • 13.4.2 Market Performance

      • 13.4.3 Product and Service Introduction

    • 13.5 Cosmo Pharmaceuticals

      • 13.5.1 Cosmo Pharmaceuticals Company Profile and Recent Development

      • 13.5.2 Market Performance

      • 13.5.3 Product and Service Introduction

    • 13.6 Allergan

      • 13.6.1 Allergan Company Profile and Recent Development

      • 13.6.2 Market Performance

      • 13.6.3 Product and Service Introduction

    • 13.7 AstraZeneca

      • 13.7.1 AstraZeneca Company Profile and Recent Development

      • 13.7.2 Market Performance

      • 13.7.3 Product and Service Introduction

    • 13.8 GlaxoSmithKline

      • 13.8.1 GlaxoSmithKline Company Profile and Recent Development

      • 13.8.2 Market Performance

      • 13.8.3 Product and Service Introduction

    • 13.9 Elan Corporation

      • 13.9.1 Elan Corporation Company Profile and Recent Development

      • 13.9.2 Market Performance

      • 13.9.3 Product and Service Introduction

    • 13.10 Amylin Pharmaceuticals

      • 13.10.1 Amylin Pharmaceuticals Company Profile and Recent Development

      • 13.10.2 Market Performance

      • 13.10.3 Product and Service Introduction

    • 13.11 Egalet

      • 13.11.1 Egalet Company Profile and Recent Development

      • 13.11.2 Market Performance

      • 13.11.3 Product and Service Introduction

    • 13.12 Flamel Technologies

      • 13.12.1 Flamel Technologies Company Profile and Recent Development

      • 13.12.2 Market Performance

      • 13.12.3 Product and Service Introduction

    • 13.13 Collegium Pharmaceutical

      • 13.13.1 Collegium Pharmaceutical Company Profile and Recent Development

      • 13.13.2 Market Performance

      • 13.13.3 Product and Service Introduction

    • 13.14 BioAlliance Pharma

      • 13.14.1 BioAlliance Pharma Company Profile and Recent Development

      • 13.14.2 Market Performance

      • 13.14.3 Product and Service Introduction

    • 13.15 Controlled Therapeutics (Ferring Pharmaceuticals)

      • 13.15.1 Controlled Therapeutics (Ferring Pharmaceuticals) Company Profile and Recent Development

      • 13.15.2 Market Performance

      • 13.15.3 Product and Service Introduction

    The List of Tables and Figures

    • Figure Product Picture

    • Figure China Controlled-release Drug Delivery Technology Market Size and Growth Rate of Wurster Technique from 2016 to 2027

    • Figure China Controlled-release Drug Delivery Technology Market Size and Growth Rate of Coacervation from 2016 to 2027

    • Figure China Controlled-release Drug Delivery Technology Market Size and Growth Rate of Micro Encapsulation from 2016 to 2027

    • Figure China Controlled-release Drug Delivery Technology Market Size and Growth Rate of Implants from 2016 to 2027

    • Figure China Controlled-release Drug Delivery Technology Market Size and Growth Rate of Transdermal from 2016 to 2027

    • Figure China Controlled-release Drug Delivery Technology Market Size and Growth Rate of Targeted Delivery from 2016 to 2027

    • Figure China Controlled-release Drug Delivery Technology Market Size and Growth Rate of Others from 2016 to 2027

    • Figure Market Share by Type in 2016

    • Figure Market Share by Type in 2021

    • Figure Market Share by Type in 2027

    • Figure China Controlled-release Drug Delivery Technology Market Size and Growth Rate of Metered Dose Inhalers from 2016 to 2027

    • Figure China Controlled-release Drug Delivery Technology Market Size and Growth Rate of Injectables from 2016 to 2027

    • Figure China Controlled-release Drug Delivery Technology Market Size and Growth Rate of Transdermal and Ocular Patches from 2016 to 2027

    • Figure China Controlled-release Drug Delivery Technology Market Size and Growth Rate of Infusion Pumps from 2016 to 2027

    • Figure China Controlled-release Drug Delivery Technology Market Size and Growth Rate of Oral Controlled-Drug Delivery Systems from 2016 to 2027

    • Figure China Controlled-release Drug Delivery Technology Market Size and Growth Rate of Drug Eluting Stents from 2016 to 2027

    • Figure China Controlled-release Drug Delivery Technology Market Size and Growth Rate of Other from 2016 to 2027

    • Figure Market Share by End-User in 2016

    • Figure Market Share by End-User in 2021

    • Figure Market Share by End-User in 2027

    • Figure North China Controlled-release Drug Delivery Technology Consumption Market Size and Growth Rate from 2016 to 2027

    • Figure Central China Controlled-release Drug Delivery Technology Consumption Market Size and Growth Rate from 2016 to 2027

    • Figure South China Controlled-release Drug Delivery Technology Consumption Market Size and Growth Rate from 2016 to 2027

    • Figure East China Controlled-release Drug Delivery Technology Consumption Market Size and Growth Rate from 2016 to 2027

    • Figure Northeast China Controlled-release Drug Delivery Technology Consumption Market Size and Growth Rate from 2016 to 2027

    • Figure Southwest China Controlled-release Drug Delivery Technology Consumption Market Size and Growth Rate from 2016 to 2027

    • Figure Northwest China Controlled-release Drug Delivery Technology Consumption Market Size and Growth Rate from 2016 to 2027

    • Figure Development Trends and Industry Dynamics of Controlled-release Drug Delivery Technology Industry

    • Figure Market Challenges and Restraints

    • Figure Market Opportunities and Potentials

    • Table Mergers and Acquisition

    • Figure Market Share of TOP 3 Players in 2020

    • Figure Market Share of TOP 5 Players in 2021

    • Figure Market Share of TOP 6 Players from 2016 to 2021

    • Figure Porter's Five Forces Analysis

    • Figure New Entrant SWOT Analysis

    • Figure Coronavirus (COVID-19) Map of China

    • Table Coronavirus (COVID-19) Impact on the Industry

    • Figure Specifications of Different Types of Controlled-release Drug Delivery Technology

    • Figure Development Trends of Different Types

    • Table Commercial Products Types of Major Vendors

    • Figure Competitive Landscape Analysis of Different Types

    • Table Consumption of Controlled-release Drug Delivery Technology by Different Types from 2016 to 2027

    • Table Consumption Share of Controlled-release Drug Delivery Technology by Different Types from 2016 to 2027

    • Figure Market Size and Growth Rate of Wurster Technique

    • Figure Market Size and Growth Rate of Coacervation

    • Figure Market Size and Growth Rate of Micro Encapsulation

    • Figure Market Size and Growth Rate of Implants

    • Figure Market Size and Growth Rate of Transdermal

    • Figure Market Size and Growth Rate of Targeted Delivery

    • Figure Market Size and Growth Rate of Others

    • Table Downstream Client Analysis by End-Users

    • Figure Competitive Landscape Analysis of Different End-Users

    • Table Market Potential Analysis of Different End-Users

    • Figure Consumption of Controlled-release Drug Delivery Technology by Different End-Users from 2016 to 2027

    • Table Consumption Share of Controlled-release Drug Delivery Technology by Different End-Users from 2016 to 2027

    • Figure Market Size and Growth Rate of Metered Dose Inhalers

    • Figure Market Size and Growth Rate of Injectables

    • Figure Market Size and Growth Rate of Transdermal and Ocular Patches

    • Figure Market Size and Growth Rate of Infusion Pumps

    • Figure Market Size and Growth Rate of Oral Controlled-Drug Delivery Systems

    • Figure Market Size and Growth Rate of Drug Eluting Stents

    • Figure Market Size and Growth Rate of Other

    • Table China Controlled-release Drug Delivery Technology Production by Regions

    • Table China Controlled-release Drug Delivery Technology Production Share by Regions

    • Figure China Controlled-release Drug Delivery Technology Production Share by Regions in 2016

    • Figure China Controlled-release Drug Delivery Technology Production Share by Regions in 2021

    • Figure China Controlled-release Drug Delivery Technology Production Share by Regions in 2027

    • Table China Controlled-release Drug Delivery Technology Consumption by Regions

    • Table China Controlled-release Drug Delivery Technology Consumption Share by Regions

    • Figure China Controlled-release Drug Delivery Technology Consumption Share by Regions in 2016

    • Figure China Controlled-release Drug Delivery Technology Consumption Share by Regions in 2021

    • Figure China Controlled-release Drug Delivery Technology Consumption Share by Regions in 2027

    • Table North China Controlled-release Drug Delivery Technology Consumption by Types from 2016 to 2027

    • Table North China Controlled-release Drug Delivery Technology Consumption Share by Types from 2016 to 2027

    • Figure North China Controlled-release Drug Delivery Technology Consumption Share by Types in 2016

    • Figure North China Controlled-release Drug Delivery Technology Consumption Share by Types in 2021

    • Figure North China Controlled-release Drug Delivery Technology Consumption Share by Types in 2027

    • Table North China Controlled-release Drug Delivery Technology Consumption by End-Users from 2016 to 2027

    • Table North China Controlled-release Drug Delivery Technology Consumption Share by End-Users from 2016 to 2027

    • Figure North China Controlled-release Drug Delivery Technology Consumption Share by End-Users in 2016

    • Figure North China Controlled-release Drug Delivery Technology Consumption Share by End-Users in 2021

    • Figure North China Controlled-release Drug Delivery Technology Consumption Share by End-Users in 2027

    • Table Central China Controlled-release Drug Delivery Technology Consumption by Types from 2016 to 2027

    • Table Central China Controlled-release Drug Delivery Technology Consumption Share by Types from 2016 to 2027

    • Figure Central China Controlled-release Drug Delivery Technology Consumption Share by Types in 2016

    • Figure Central China Controlled-release Drug Delivery Technology Consumption Share by Types in 2021

    • Figure Central China Controlled-release Drug Delivery Technology Consumption Share by Types in 2027

    • Table Central China Controlled-release Drug Delivery Technology Consumption by End-Users from 2016 to 2027

    • Table Central China Controlled-release Drug Delivery Technology Consumption Share by End-Users from 2016 to 2027

    • Figure Central China Controlled-release Drug Delivery Technology Consumption Share by End-Users in 2016

    • Figure Central China Controlled-release Drug Delivery Technology Consumption Share by End-Users in 2021

    • Figure Central China Controlled-release Drug Delivery Technology Consumption Share by End-Users in 2027

    • Table South China Controlled-release Drug Delivery Technology Consumption by Types from 2016 to 2027

    • Table South China Controlled-release Drug Delivery Technology Consumption Share by Types from 2016 to 2027

    • Figure South China Controlled-release Drug Delivery Technology Consumption Share by Types in 2016

    • Figure South China Controlled-release Drug Delivery Technology Consumption Share by Types in 2021

    • Figure South China Controlled-release Drug Delivery Technology Consumption Share by Types in 2027

    • Table South China Controlled-release Drug Delivery Technology Consumption by End-Users from 2016 to 2027

    • Table South China Controlled-release Drug Delivery Technology Consumption Share by End-Users from 2016 to 2027

    • Figure South China Controlled-release Drug Delivery Technology Consumption Share by End-Users in 2016

    • Figure South China Controlled-release Drug Delivery Technology Consumption Share by End-Users in 2021

    • Figure South China Controlled-release Drug Delivery Technology Consumption Share by End-Users in 2027

    • Table East China Controlled-release Drug Delivery Technology Consumption by Types from 2016 to 2027

    • Table East China Controlled-release Drug Delivery Technology Consumption Share by Types from 2016 to 2027

    • Figure East China Controlled-release Drug Delivery Technology Consumption Share by Types in 2016

    • Figure East China Controlled-release Drug Delivery Technology Consumption Share by Types in 2021

    • Figure East China Controlled-release Drug Delivery Technology Consumption Share by Types in 2027

    • Table East China Controlled-release Drug Delivery Technology Consumption by End-Users from 2016 to 2027

    • Table East China Controlled-release Drug Delivery Technology Consumption Share by End-Users from 2016 to 2027

    • Figure East China Controlled-release Drug Delivery Technology Consumption Share by End-Users in 2016

    • Figure East China Controlled-release Drug Delivery Technology Consumption Share by End-Users in 2021

    • Figure East China Controlled-release Drug Delivery Technology Consumption Share by End-Users in 2027

    • Table Northeast China Controlled-release Drug Delivery Technology Consumption by Types from 2016 to 2027

    • Table Northeast China Controlled-release Drug Delivery Technology Consumption Share by Types from 2016 to 2027

    • Figure Northeast China Controlled-release Drug Delivery Technology Consumption Share by Types in 2016

    • Figure Northeast China Controlled-release Drug Delivery Technology Consumption Share by Types in 2021

    • Figure Northeast China Controlled-release Drug Delivery Technology Consumption Share by Types in 2027

    • Table Northeast China Controlled-release Drug Delivery Technology Consumption by End-Users from 2016 to 2027

    • Table Northeast China Controlled-release Drug Delivery Technology Consumption Share by End-Users from 2016 to 2027

    • Figure Northeast China Controlled-release Drug Delivery Technology Consumption Share by End-Users in 2016

    • Figure Northeast China Controlled-release Drug Delivery Technology Consumption Share by End-Users in 2021

    • Figure Northeast China Controlled-release Drug Delivery Technology Consumption Share by End-Users in 2027

    • Table Southwest China Controlled-release Drug Delivery Technology Consumption by Types from 2016 to 2027

    • Table Southwest China Controlled-release Drug Delivery Technology Consumption Share by Types from 2016 to 2027

    • Figure Southwest China Controlled-release Drug Delivery Technology Consumption Share by Types in 2016

    • Figure Southwest China Controlled-release Drug Delivery Technology Consumption Share by Types in 2021

    • Figure Southwest China Controlled-release Drug Delivery Technology Consumption Share by Types in 2027

    • Table Southwest China Controlled-release Drug Delivery Technology Consumption by End-Users from 2016 to 2027

    • Table Southwest China Controlled-release Drug Delivery Technology Consumption Share by End-Users from 2016 to 2027

    • Figure Southwest China Controlled-release Drug Delivery Technology Consumption Share by End-Users in 2016

    • Figure Southwest China Controlled-release Drug Delivery Technology Consumption Share by End-Users in 2021

    • Figure Southwest China Controlled-release Drug Delivery Technology Consumption Share by End-Users in 2027

    • Table Northwest China Controlled-release Drug Delivery Technology Consumption by Types from 2016 to 2027

    • Table Northwest China Controlled-release Drug Delivery Technology Consumption Share by Types from 2016 to 2027

    • Figure Northwest China Controlled-release Drug Delivery Technology Consumption Share by Types in 2016

    • Figure Northwest China Controlled-release Drug Delivery Technology Consumption Share by Types in 2021

    • Figure Northwest China Controlled-release Drug Delivery Technology Consumption Share by Types in 2027

    • Table Northwest China Controlled-release Drug Delivery Technology Consumption by End-Users from 2016 to 2027

    • Table Northwest China Controlled-release Drug Delivery Technology Consumption Share by End-Users from 2016 to 2027

    • Figure Northwest China Controlled-release Drug Delivery Technology Consumption Share by End-Users in 2016

    • Figure Northwest China Controlled-release Drug Delivery Technology Consumption Share by End-Users in 2021

    • Figure Northwest China Controlled-release Drug Delivery Technology Consumption Share by End-Users in 2027

    • Table Company Profile and Development Status of iCeutica

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of iCeutica

    • Figure Sales and Growth Rate Analysis of iCeutica

    • Figure Revenue and Market Share Analysis of iCeutica

    • Table Product and Service Introduction of iCeutica

    • Table Company Profile and Development Status of Heron Therapeutics

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Heron Therapeutics

    • Figure Sales and Growth Rate Analysis of Heron Therapeutics

    • Figure Revenue and Market Share Analysis of Heron Therapeutics

    • Table Product and Service Introduction of Heron Therapeutics

    • Table Company Profile and Development Status of Encore Therapeutics

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Encore Therapeutics

    • Figure Sales and Growth Rate Analysis of Encore Therapeutics

    • Figure Revenue and Market Share Analysis of Encore Therapeutics

    • Table Product and Service Introduction of Encore Therapeutics

    • Table Company Profile and Development Status of Biogen

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Biogen

    • Figure Sales and Growth Rate Analysis of Biogen

    • Figure Revenue and Market Share Analysis of Biogen

    • Table Product and Service Introduction of Biogen

    • Table Company Profile and Development Status of Cosmo Pharmaceuticals

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Cosmo Pharmaceuticals

    • Figure Sales and Growth Rate Analysis of Cosmo Pharmaceuticals

    • Figure Revenue and Market Share Analysis of Cosmo Pharmaceuticals

    • Table Product and Service Introduction of Cosmo Pharmaceuticals

    • Table Company Profile and Development Status of Allergan

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Allergan

    • Figure Sales and Growth Rate Analysis of Allergan

    • Figure Revenue and Market Share Analysis of Allergan

    • Table Product and Service Introduction of Allergan

    • Table Company Profile and Development Status of AstraZeneca

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of AstraZeneca

    • Figure Sales and Growth Rate Analysis of AstraZeneca

    • Figure Revenue and Market Share Analysis of AstraZeneca

    • Table Product and Service Introduction of AstraZeneca

    • Table Company Profile and Development Status of GlaxoSmithKline

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of GlaxoSmithKline

    • Figure Sales and Growth Rate Analysis of GlaxoSmithKline

    • Figure Revenue and Market Share Analysis of GlaxoSmithKline

    • Table Product and Service Introduction of GlaxoSmithKline

    • Table Company Profile and Development Status of Elan Corporation

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Elan Corporation

    • Figure Sales and Growth Rate Analysis of Elan Corporation

    • Figure Revenue and Market Share Analysis of Elan Corporation

    • Table Product and Service Introduction of Elan Corporation

    • Table Company Profile and Development Status of Amylin Pharmaceuticals

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Amylin Pharmaceuticals

    • Figure Sales and Growth Rate Analysis of Amylin Pharmaceuticals

    • Figure Revenue and Market Share Analysis of Amylin Pharmaceuticals

    • Table Product and Service Introduction of Amylin Pharmaceuticals

    • Table Company Profile and Development Status of Egalet

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Egalet

    • Figure Sales and Growth Rate Analysis of Egalet

    • Figure Revenue and Market Share Analysis of Egalet

    • Table Product and Service Introduction of Egalet

    • Table Company Profile and Development Status of Flamel Technologies

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Flamel Technologies

    • Figure Sales and Growth Rate Analysis of Flamel Technologies

    • Figure Revenue and Market Share Analysis of Flamel Technologies

    • Table Product and Service Introduction of Flamel Technologies

    • Table Company Profile and Development Status of Collegium Pharmaceutical

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Collegium Pharmaceutical

    • Figure Sales and Growth Rate Analysis of Collegium Pharmaceutical

    • Figure Revenue and Market Share Analysis of Collegium Pharmaceutical

    • Table Product and Service Introduction of Collegium Pharmaceutical

    • Table Company Profile and Development Status of BioAlliance Pharma

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of BioAlliance Pharma

    • Figure Sales and Growth Rate Analysis of BioAlliance Pharma

    • Figure Revenue and Market Share Analysis of BioAlliance Pharma

    • Table Product and Service Introduction of BioAlliance Pharma

    • Table Company Profile and Development Status of Controlled Therapeutics (Ferring Pharmaceuticals)

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Controlled Therapeutics (Ferring Pharmaceuticals)

    • Figure Sales and Growth Rate Analysis of Controlled Therapeutics (Ferring Pharmaceuticals)

    • Figure Revenue and Market Share Analysis of Controlled Therapeutics (Ferring Pharmaceuticals)

    • Table Product and Service Introduction of Controlled Therapeutics (Ferring Pharmaceuticals)


Report Version Choose

Report

BUY NOW

Our Customers

Beyond grateful for the confidence and support from all partners and customers.A win-win situation is our ultimate pursuit.

Beyond Consulting, Future is Feasible

We provide more professional and intelligent market reports to complement your business decisions.

CONTACT US